NCT07663500 Integrated Intrapartum Supportive Care and Pushing Strategies in Women Receiving Low-Dose Epidural Analgesia
| NCT ID | NCT07663500 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taipei University of Nursing and Health Sciences |
| Condition | Labor, Obstetric |
| Study Type | INTERVENTIONAL |
| Enrollment | 159 participants |
| Start Date | 2025-06-10 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 159 participants in total. It began in 2025-06-10 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, three-arm, non-randomized quasi-experimental study aims to evaluate integrated intrapartum supportive care combined with different pushing strategies among women at 37-42 weeks of gestation who receive low-dose epidural analgesia. Participants receive integrated intrapartum supportive care combined with spontaneous pushing, integrated intrapartum supportive care combined with immediate pushing, or routine intrapartum care combined with immediate pushing. The primary outcomes are the durations of the first and second stages of labor. Secondary outcomes include mode of birth, obstetric interventions, maternal outcomes, and neonatal outcomes.
Eligibility Criteria
Inclusion Criteria:low-risk pregnant women aged 18 years or older with a singleton, term pregnancy (37-42 weeks), spontaneous labor onset, and planning to receive low-dose epidural analgesia. Exclusion Criteria: Exclusion Criteria: multiple gestation, non-cephalic presentation, known major fetal anomalies, planned cesarean birth, contraindications to vaginal birth, contraindications to maternal mobility or epidural analgesia, or inability to provide informed consent.
Contact & Investigator
Wan-Lin Pan, PhD
PRINCIPAL INVESTIGATOR
National Taipei University of Nursing and Health Sciences
Frequently Asked Questions
Who can join the NCT07663500 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Labor, Obstetric. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07663500 currently recruiting?
Yes, NCT07663500 is actively recruiting participants. Contact the research team at wanlimp@gmail.com for enrollment information.
Where is the NCT07663500 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07663500 clinical trial?
NCT07663500 is sponsored by National Taipei University of Nursing and Health Sciences. The principal investigator is Wan-Lin Pan, PhD at National Taipei University of Nursing and Health Sciences. The trial plans to enroll 159 participants.